Search Results - "Stalenhoef, A.F.H."

Refine Results
  1. 1

    Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: A crucial role for Krüppel-like factor 2 by van Tits, L.J.H, Stienstra, R, van Lent, P.L, Netea, M.G, Joosten, L.A.B, Stalenhoef, A.F.H

    Published in Atherosclerosis (01-02-2011)
    “…Abstract Objective Macrophages are key players in atherogenesis because of their properties to form foam cells that produce a large variety of pro-inflammatory…”
    Get full text
    Journal Article
  2. 2

    Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands by Pijlman, A.H, Huijgen, R, Verhagen, S.N, Imholz, B.P.M, Liem, A.H, Kastelein, J.J.P, Abbink, E.J, Stalenhoef, A.F.H, Visseren, F.L.J

    Published in Atherosclerosis (01-03-2010)
    “…Abstract Background Heterozygous familial hypercholesterolemia (heFH) is a common autosomal dominant hereditary disorder caused by mutations in the…”
    Get full text
    Journal Article
  3. 3

    Role of Insulin Resistance in Familial Combined Hyperlipidemia by Veerkamp, M J, de Graaf, J, Stalenhoef, A F.H

    “…OBJECTIVE—Insulin resistance is associated with increased triglyceride levels, low high-density lipoprotein cholesterol, small dense low-density lipoprotein…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation by van Tits, L.J.H, Jacobs, E.M.G, Swinkels, D.W, Lemmers, H.L.M, van der Vleuten, G.M, de Graaf, J, Stalenhoef, A.F.H

    Published in Atherosclerosis (01-09-2007)
    “…Abstract Background Excess body iron is associated with increased cardiovascular disease risk, possibly via non-transferrin-bound iron (NTBI)-mediated…”
    Get full text
    Journal Article
  8. 8
  9. 9

    2.5 The Additive Value of Measuring Subclinical Atherosclerosis is Gender Specific by Holewijn, S., den Heijer, M., Swinkels, D. W., Stalenhoef, A. F. H., de Graaf, J.

    Published in Artery research (2012)
    “…Aim Cardiovascular disease (CV) risk-stratification could be improved by adding measures of (subclinical) atherosclerosis to current risk scores, especially in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    P9.05 Impact of Interleukin-18 and Obesity on Subclinical Atherosclerosis in the General Population by Holewijn, S., den Heijer, M., Swinkels, D. W., Stalenhoef, A. F. H., de Graaf, J.

    Published in Artery research (01-12-2010)
    “…Objective The prevalence of obesity and consequently the risk for cardiovascular diseases(CVD) increases dramatically worldwide. It has been suggested that…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    6.6 Waist Circumference Is A Better Predictor Of Subclinical Atherosclerosis Than Adiponectin Level by Holewijn, S., den Heijer, M., van Tits, L. J., Swinkels, D. W., Stalenhoef, A. F. H., de Graaf, J.

    Published in Artery research (01-12-2009)
    “…Objective Waist circumference is clinical marker of obesity and a well-established risk factor for cardiovascular disease. Adiponectin, an adipo-cyte-derived…”
    Get full text
    Journal Article
  15. 15

    P2.52 Association between PWV and Different Definitions of the Metabolic Syndrome by Holewijn, S., den Heijer, M., Stalenhoef, A. F. H., de Graaf, J.

    Published in Artery research (2008)
    “…Objectives To explore 1. the presence of arterial stiffness, as measured with pulse wave velocity (PWV) in subjects with the Metabolic Syndrome (MetS) and 2…”
    Get full text
    Journal Article
  16. 16

    Smoking characteristics, antioxidant vitamins, and carotid artery wall thickness among life-long smokers by de Waart, F.G., Smilde, T.J., Wollersheim, H., Stalenhoef, A.F.H., Kok, F.J.

    Published in Journal of clinical epidemiology (01-07-2000)
    “…We studied the associations between the common carotid-intima-media thickness (IMT), as a marker of atherosclerosis, and smoking characteristics and…”
    Get full text
    Journal Article
  17. 17

    P.058 ENDOTHELIAL DYSFUNCTION AS MEASURED BY FLOW MEDIATED DILATATION (FMD) IN CARDIOVASCULAR RISK ASSESSMENT by Holewijn, S., de Graaf, J., den Heijer, M., Stalenhoef, A.F.H.

    Published in Artery research (01-09-2007)
    “…IntroductionFMD has been proposed as a tool in cardiovascular (CV) risk stratification. However, this has only been studied in relatively small, high risk…”
    Get full text
    Journal Article
  18. 18

    Segregation Analysis of Plasma Apolipoprotein B Levels in Familial Combined Hyperlipidemia by Bredie, S.J.H, van Drongelen, J, Kiemeney, L.A, Demacker, P.N.M, Beaty, T.H, Stalenhoef, A.F.H

    “…Familial combined hyperlipidemia (FCH) is a heritable lipid disorder that is associated with an increased risk of premature cardiovascular disease. An elevated…”
    Get full text
    Journal Article
  19. 19
  20. 20